Jing-Quan Lim

14PUBLICATIONS
80CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityInnate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 15, 2025
Priming with DNMT Inhibitors Potentiates PD-1 Immunotherapy by Triggering Viral Mimicry in Relapsed/Refractory NK/T-cell Lymphoma.

Cheng Huang, Yan Gao, Jianfeng Chen

|Mar 12, 2025
Efficacy of combined CD38 and PD-1 inhibition with isatuximab and cemiplimab for relapsed/refractory NK/T-cell lymphoma.

Seok Jin Kim, Jing Quan Lim, Sang Eun Yoon

|Jan 03, 2024
Single-cell landscape of idiopathic multicentric Castleman disease in identical twins.

Jason Yongsheng Chan, Jui Wan Loh, Jing Quan Lim

|Apr 27, 2023
Spatial transcriptomics reveal topological immune landscapes of Asian head and neck angiosarcoma.

Jui Wan Loh, Jing Yi Lee, Abner Herbert Lim

|Nov 29, 2022
Sustained activation of non-canonical NF-κB signalling drives glycolytic reprogramming in doxorubicin-resistant DLBCL.

Shen Kiat Lim, Chen Chen Peng, Shannon Low

|Jun 21, 2022
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort.

Jing Quan Lim, Dachuan Huang, Jason Yongsheng Chan

Pageof 3

Frequent Collaborators

8 joint publications

Choon Kiat Ong

6 joint publications

Soon Thye Lim

4 joint publications

Bin Tean Teh

3 joint publications

Jason Yongsheng Chan